Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၁.၄၀%
၁,၀၇၆.၂၀
-၁၅.၃၁
-၁.၄၀%
—၁,၀၉၁.၅၁၁,၀၉၀.၄၀၁,၀၉၀.၄၀၁,၀၇၄.၆၅——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၃၉%
၆၀၇.၇၆
-၂.၃၅
-၀.၃၉%
—၆၁၀.၁၁၆၁၀.၁၁၆၁၀.၂၉၆၀၆.၁၇——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၆၁%
၁,၂၄၅.၄၉
+၇.၅၁
+၀.၆၁%
—၁,၂၃၇.၉၈၁,၂၃၇.၈၃၁,၂၅၂.၄၁၁,၂၂၅.၀၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၀၅%
၁,၇၂၆.၃၁
-၁၈.၄၀
-၁.၀၅%
—၁,၇၄၄.၇၁၁,၇၄၀.၉၅၁,၇၄၇.၂၉၁,၇၂၁.၅၇——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၅၆%
၆၃၆.၅၈
-၃.၆၀
-၀.၅၆%
—၆၄၀.၁၈၆၃၉.၉၂၆၄၃.၁၉၆၃၄.၇၃——
SIXR
Staples
SIXR
Staples
SIXR
-၁.၀၃%
၈၄၀.၈၀
-၈.၇၈
-၁.၀၃%
—၈၄၉.၅၈၈၄၅.၂၇၈၅၁.၆၈၈၃၉.၄၇——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၈၀%
၂၁၅.၇၄
-၁.၇၄
-၀.၈၀%
—၂၁၇.၄၈၂၁၇.၄၈၂၁၈.၁၆၂၁၅.၅၁——
SIXT
Technology
SIXT
Technology
SIXT
+၀.၂၃%
၃,၂၆၈.၂၂
+၇.၅၃
+၀.၂၃%
—၃,၂၆၀.၆၉၃,၂၇၃.၃၆၃,၂၈၇.၈၁၃,၂၄၀.၇၈——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၅၅%
၉၃၇.၃၀
-၅.၁၅
-၀.၅၅%
—၉၄၂.၄၅၉၃၉.၃၉၉၄၈.၈၀၉၃၃.၉၈——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၂၄%
၁,၄၆၃.၂၇
-၃.၅၃
-၀.၂၄%
—၁,၄၆၆.၈၀၁,၄၆၄.၇၀၁,၄၆၇.၁၉၁,၄၅၈.၃၆——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၀.၆၇%
၂,၃၈၁.၄၃
-၁၆.၀၇
-၀.၆၇%
—၂,၃၉၇.၅၀၂,၃၉၅.၀၃၂,၄၁၂.၀၁၂,၃၇၀.၆၄——
Q1 2026 earnings • released • EPS beat +၈.၀၄% • Revenue beat +၀.၅၅%
See results
AMG:ETR
Amgen Inc
၂၇၇.၄၀ €
-၆.၅၄%
(-၁၉.၄၀) 1D
မေ ၄, GMT+၂ ၁၇:၃၅:၃၀  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AMG...
Open
၂၈၁.၇၀ €
High
၂၈၂.၃၀ €
Low
၂၇၆.၄၅ €
Mkt. cap
ဋေ ၁.၇၄ သ
Avg. vol.
၃၁၁.၀၀
Volume
၁.၉၅ ထောင်
52-wk high
၃၃၃.၀၀ €
52-wk low
၂၃၀.၀၀ €
No. of employees
၃ သောင်း
News stories
From sources across the web
MSN
MSN
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Amgen to invest additional $300 million to boost US manufacturing footprint
Business Facilities
Business Facilities
·
ပြီးခဲ့သည့် ၂ နာရီ
Amgen Expands U.S. Investment With $600M In Puerto Rico
TIKR.com
TIKR.com
·
ပြီးခဲ့သည့် ၃ နာရီ
Pfizer vs. Amgen: Which Big Pharma Stock Is the Better Value Right Now?
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၄ နာရီ
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees၃.၁၅ သောင်း
Founded၁၉၈၀ ဧ ၈
Headquartersသောင်စင်အုက်စ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteamgen.com
Last report
၂၀၂၆ ဧ ၃၀
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၅.၁၅/ (၄.၇၇ est.)USD
+၈.၀၄%beat
Revenue / Estimate
၈၆၁.၈၀ ဋေ/ (၈၅၇.၀၆ ဋေ est.)USD
+၀.၅၅%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၉၁၇.၉၀ ဋေ
၉၅၅.၇၀ ဋေ
၉၈၆.၆၀ ဋေ
၈၆၁.၈၀ ဋေ
Cost of goods sold
၂၆၇.၂၀ ဋေ
၂၇၄.၄၀ ဋေ
၂၆၇.၆၀ ဋေ
၂၇၄.၄၀ ဋေ
Cost of revenue
၂၆၇.၂၀ ဋေ
၂၇၄.၄၀ ဋေ
၂၆၇.၆၀ ဋေ
၂၇၄.၄၀ ဋေ
Research and development expenses
၁၇၄.၄၀ ဋေ
၁၉၀.၀၀ ဋေ
၂၁၄.၂၀ ဋေ
၁၇၁.၉၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၆၉.၁၀ ဋေ
၁၇၂.၀၀ ဋေ
၁၉၅.၂၀ ဋေ
၁၅၈.၃၀ ဋေ
Operating expense
၃၅၀.၃၀ ဋေ
၃၅၄.၉၀ ဋေ
၄၁၇.၆၀ ဋေ
၃၁၆.၉၀ ဋေ
Total operating expenses
၆၁၇.၅၀ ဋေ
၆၂၉.၃၀ ဋေ
၆၈၅.၂၀ ဋေ
၅၉၁.၃၀ ဋေ
Operating income
၃၀၀.၄၀ ဋေ
၃၂၆.၄၀ ဋေ
၃၀၁.၄၀ ဋေ
၂၇၀.၅၀ ဋေ
Other non operating income
-၁၁.၃၀ ကုဋေ
၁၈.၁၀ ကုဋေ
၁၄.၃၀ ကုဋေ
၁၇.၇၀ ကုဋေ
EBT including unusual items
၁၅၆.၈၀ ဋေ
၃၉၂.၁၀ ဋေ
၁၅၁.၄၀ ဋေ
၂၀၈.၄၀ ဋေ
EBT excluding unusual items
၂၃၆.၉၀ ဋေ
၂၇၂.၁၀ ဋေ
၂၅၀.၉၀ ဋေ
၂၂၂.၅၀ ဋေ
Income tax expense
၁၃.၆၀ ကုဋေ
၇၀.၅၀ ကုဋေ
၁၈.၁၀ ကုဋေ
၂၆.၅၀ ကုဋေ
Effective tax rate
၈.၆၇%
၁၇.၉၈%
၁၁.၉၆%
၁၂.၇၂%
Other operating expenses
၆.၈၀ ကုဋေ
-၇.၁၀ ကုဋေ
၈.၂၀ ကုဋေ
-၁၃.၃၀ ကုဋေ
Net income
၁၄၃.၂၀ ဋေ
၃၂၁.၆၀ ဋေ
၁၃၃.၃၀ ဋေ
၁၈၁.၉၀ ဋေ
Net profit margin
၁၅.၆၀%
၃၃.၆၅%
၁၃.၅၁%
၂၁.၁၁%
Earnings per share
၆.၀၂
၅.၆၄
၅.၂၉
၅.၁၅
Interest and investment income
-
-
၄၀.၈၀ ကုဋေ
-
Interest expense
-၆၉.၄၀ ကုဋေ
-၆၈.၅၀ ကုဋေ
-၁၀၆.၁၀ ဋေ
-၆၅.၇၀ ကုဋေ
Net interest expenses
-၆၉.၄၀ ကုဋေ
-၆၈.၅၀ ကုဋေ
-၆၅.၃၀ ကုဋေ
-၆၅.၇၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၃၄.၅၀ ဋေ
၄၅၇.၁၀ ဋေ
၄၀၂.၂၀ ဋေ
၃၉၆.၅၈ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer